Aug. 3 at 3:27 AM
$IQST - Riddle me this back:
What company begins with an “I” and ends in a “T” that:
Grew revenue from under 39 M just a few years ago to
$283M in 2024 and ~
$317M in 2025
Just reported
$207M in the first half of 2026 alone (up 59% year-over-year)
Is on a clear path to a
$500M+ annual revenue run rate this year (with Ultranet) and has a public target of
$1 billion by 2027
Successfully uplisted to Nasdaq in May 2025 via direct listing (no capital raise dilution)
Has already reached positive Adjusted EBITDA run rates from its operating businesses and is now positioning for
$8M+ EBITDA with the Ultranet deal
Continues expanding into higher-margin verticals (AI, Cybersecurity, Fintech) while scaling its core telecom platform across 20+ countries
Yes, there were historical dilutions — almost every high-growth OTC company that scaled this aggressively used equity to fund acquisitions and growth. That’s how you go from tiny to hundreds of millions in revenue.
